Literature DB >> 32345833

Treatment in Disproportionately Minority Hospitals Is Associated With Increased Risk of Mortality in Sepsis: A National Analysis.

Barret Rush1, John Danziger2, Keith R Walley3, Anand Kumar1, Leo Anthony Celi2.   

Abstract

OBJECTIVES: Treatment in a disproportionately minority-serving hospital has been associated with worse outcomes in a variety of illnesses. We examined the association of treatment in disproportionately minority hospitals on outcomes in patients with sepsis across the United States.
DESIGN: Retrospective cohort analysis. Disproportionately minority hospitals were defined as hospitals having twice the relative minority patient population than the surrounding geographical mean. Minority hospitals for Black and Hispanic patient populations were identified based on U.S. Census demographic information. A multivariate model employing a validated algorithm for mortality in sepsis using administrative data was used.
SETTING: The National Inpatient Sample from 2008 to 2014. PATIENTS: Patients over 18 years of age with sepsis.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: A total of 4,221,221 patients with sepsis were identified. Of these, 612,217 patients (14.5%) were treated at hospitals disproportionately serving the black community (Black hospitals), whereas 181,141 (4.3%) were treated at hospitals disproportionately serving the Hispanic community (Hispanic hospitals). After multivariate analysis, treatment in a Black hospital was associated with a 4% higher risk of mortality compared to treatment in a nonminority hospital (odds ratio, 1.04; 95% CI, 1.03-1.05; p < 0.01). Treatment in a Hispanic hospital was associated with a 9% higher risk of mortality (odds ratio, 1.09; 95% CI, 1.07-1.11; p < 0.01). Median hospital length of stay was almost 1 day longer at each of the disproportionately minority hospitals (nonminority hospitals: 5.9 d; interquartile range, 3.1-11.0 d vs Hispanic: 6.9 d; interquartile range, 3.6-12.9 d and Black: 6.7 d, interquartile range, 3.4-13.2 d; both p < 0.01).
CONCLUSIONS: Patients with sepsis regardless of race who were treated in disproportionately high minority hospitals suffered significantly higher rates of in-hospital mortality.

Entities:  

Mesh:

Year:  2020        PMID: 32345833      PMCID: PMC8085686          DOI: 10.1097/CCM.0000000000004375

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  28 in total

1.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Authors:  Anand Kumar; Daniel Roberts; Kenneth E Wood; Bruce Light; Joseph E Parrillo; Satendra Sharma; Robert Suppes; Daniel Feinstein; Sergio Zanotti; Leo Taiberg; David Gurka; Aseem Kumar; Mary Cheang
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

2.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

3.  Primary Care Providers Perceptions of Racial/Ethnic and Socioeconomic Disparities in Hypertension Control.

Authors:  Jessica Kendrick; Eugene Nuccio; Jenn A Leiferman; Angela Sauaia
Journal:  Am J Hypertens       Date:  2015-01-27       Impact factor: 2.689

4.  Racial disparities in the quality of care for enrollees in medicare managed care.

Authors:  Eric C Schneider; Alan M Zaslavsky; Arnold M Epstein
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

5.  Racial Differences in Palliative Care Use After Stroke in Majority-White, Minority-Serving, and Racially Integrated U.S. Hospitals.

Authors:  Roland Faigle; Wendy C Ziai; Victor C Urrutia; Lisa A Cooper; Rebecca F Gottesman
Journal:  Crit Care Med       Date:  2017-12       Impact factor: 7.598

6.  Racial disparities in reported prenatal care advice from health care providers.

Authors:  M D Kogan; M Kotelchuck; G R Alexander; W E Johnson
Journal:  Am J Public Health       Date:  1994-01       Impact factor: 9.308

7.  Concentration and quality of hospitals that care for elderly black patients.

Authors:  Ashish K Jha; E John Orav; Zhonghe Li; Arnold M Epstein
Journal:  Arch Intern Med       Date:  2007-06-11

8.  Racial and Geographic Disparities in Interhospital ICU Transfers.

Authors:  Patrick D Tyler; David J Stone; Benjamin P Geisler; Stuart McLennan; Leo Anthony Celi; Barret Rush
Journal:  Crit Care Med       Date:  2018-01       Impact factor: 7.598

9.  Outcomes of Ventilated Patients With Sepsis Who Undergo Interhospital Transfer: A Nationwide Linked Analysis.

Authors:  Barret Rush; Patrick D Tyler; David J Stone; Benjamin P Geisler; Keith R Walley; Leo Anthony Celi
Journal:  Crit Care Med       Date:  2018-01       Impact factor: 7.598

10.  A Severe Sepsis Mortality Prediction Model and Score for Use With Administrative Data.

Authors:  Dee W Ford; Andrew J Goodwin; Annie N Simpson; Emily Johnson; Nandita Nadig; Kit N Simpson
Journal:  Crit Care Med       Date:  2016-02       Impact factor: 7.598

View more
  4 in total

1.  AI Ethics Is Not a Panacea.

Authors:  Stuart McLennan; Meredith M Lee; Amelia Fiske; Leo Anthony Celi
Journal:  Am J Bioeth       Date:  2020-11       Impact factor: 11.229

2.  Performance of intensive care unit severity scoring systems across different ethnicities.

Authors:  Rahuldeb Sarkar; Christopher Martin; Heather Mattie; Judy Wawira Gichoya; David J Stone; Leo Anthony Celi
Journal:  medRxiv       Date:  2021-01-20

3.  Performance of intensive care unit severity scoring systems across different ethnicities in the USA: a retrospective observational study.

Authors:  Rahuldeb Sarkar; Christopher Martin; Heather Mattie; Judy Wawira Gichoya; David J Stone; Leo Anthony Celi
Journal:  Lancet Digit Health       Date:  2021-04

4.  Use of hospitals in the New York City Metropolitan Region, by race: how separate? How equal in resources and quality?

Authors:  Bian Liu; Katherine A Ornstein; Julia L Frydman; Amy S Kelley; Emma K T Benn; Albert L Siu
Journal:  BMC Health Serv Res       Date:  2022-08-10       Impact factor: 2.908

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.